Related references
Note: Only part of the references are listed.Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells
Natalie Grinshtein et al.
CANCER RESEARCH (2011)
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
H. Takenobu et al.
ONCOGENE (2011)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens
Kristen M. Smith et al.
EMBO MOLECULAR MEDICINE (2010)
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bβ and TSLC1 in neuroblastoma
H. Ochiai et al.
ONCOGENE (2010)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
Yonatan Y. Mahller et al.
PLOS ONE (2009)
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors
Joo Mi Yi et al.
CANCER RESEARCH (2008)
Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation
Kiyohiro Ando et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
KIF1Bβ functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death
Arasambattu K. Munirajan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A. Cole et al.
MOLECULAR CANCER RESEARCH (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
The MYCN oncogene is a direct target of miR-34a
J. S. Wei et al.
ONCOGENE (2008)
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature
N. Tomioka et al.
ONCOGENE (2008)
Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell
Loen M. Hansford et al.
CANCER RESEARCH (2007)
CHD5 is a tumor suppressor at human 1p36
Anindya Bagchi et al.
CELL (2007)
Chromosome 1p and 11q deletions and outcome in neuroblastoma
EF Attiyeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical significance of serum NM23-H1 protein in neuroblastoma
J Okabe-Kado et al.
CANCER SCIENCE (2005)
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma
D Trochet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133
SV Shmelkov et al.
BLOOD (2004)
Pediatric neuroblastomas: genetic and epigenetic 'Danse Macabre'
MM van Noesel et al.
GENE (2004)
Characteristics of stem cells from human neuroblastoma cell lines and in tumors
JD Walton et al.
NEOPLASIA (2004)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
D Astuti et al.
ONCOGENE (2001)
Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein
D Corbeil et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Smallest region of overlapping deletion in I p36 in human neuroblastoma: A I Mbp cosmid and PAC contig
A Bauer et al.
GENES CHROMOSOMES & CANCER (2001)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
Share Paper
